Your browser doesn't support javascript.
loading
The autoimmune risk gene ZMIZ1 is a vitamin D responsive marker of a molecular phenotype of multiple sclerosis.
Fewings, N L; Gatt, P N; McKay, F C; Parnell, G P; Schibeci, S D; Edwards, J; Basuki, M A; Goldinger, A; Fabis-Pedrini, M J; Kermode, A G; Manrique, C P; McCauley, J L; Nickles, D; Baranzini, S E; Burke, T; Vucic, S; Stewart, G J; Booth, D R.
Afiliação
  • Fewings NL; Centre for Immunology and Allergy Research, Westmead Institute of Medical Research, University of Sydney, Sydney, New South Wales, Australia.
  • Gatt PN; Centre for Immunology and Allergy Research, Westmead Institute of Medical Research, University of Sydney, Sydney, New South Wales, Australia.
  • McKay FC; Centre for Immunology and Allergy Research, Westmead Institute of Medical Research, University of Sydney, Sydney, New South Wales, Australia.
  • Parnell GP; Centre for Immunology and Allergy Research, Westmead Institute of Medical Research, University of Sydney, Sydney, New South Wales, Australia.
  • Schibeci SD; Centre for Immunology and Allergy Research, Westmead Institute of Medical Research, University of Sydney, Sydney, New South Wales, Australia.
  • Edwards J; Centre for Immunology and Allergy Research, Westmead Institute of Medical Research, University of Sydney, Sydney, New South Wales, Australia.
  • Basuki MA; Centre for Immunology and Allergy Research, Westmead Institute of Medical Research, University of Sydney, Sydney, New South Wales, Australia.
  • Goldinger A; University of Queensland, Diamantina Institute, Translational Research Institute, The Queensland Brain Institute, University of Queensland, Australia.
  • Fabis-Pedrini MJ; Western Australian Neuroscience Research Institute, University of Western Australia, Nedlands, Western Australia, Australia; Institute for Immunology and Infectious Diseases, Murdoch University, Murdoch, Western Australia, Australia.
  • Kermode AG; Institute for Immunology and Infectious Diseases, Murdoch University, Murdoch, Western Australia, Australia.
  • Manrique CP; John P. Hussman Institute for Human Genomics and the Dr. John T. Macdonald Foundation Department of Human Genetics, University of Miami, Miller School of Medicine, Miami, FL 33136, USA.
  • McCauley JL; John P. Hussman Institute for Human Genomics and the Dr. John T. Macdonald Foundation Department of Human Genetics, University of Miami, Miller School of Medicine, Miami, FL 33136, USA.
  • Nickles D; Department of Neurology, University of California San Francisco, USA.
  • Baranzini SE; Department of Neurology, University of California San Francisco, USA.
  • Burke T; Western Clinical School, University of Sydney, Westmead Hospital, Sydney, New South Wales, Australia.
  • Vucic S; Centre for Immunology and Allergy Research, Westmead Institute of Medical Research, University of Sydney, Sydney, New South Wales, Australia; Western Clinical School, University of Sydney, Westmead Hospital, Sydney, New South Wales, Australia.
  • Stewart GJ; Centre for Immunology and Allergy Research, Westmead Institute of Medical Research, University of Sydney, Sydney, New South Wales, Australia; Western Clinical School, University of Sydney, Westmead Hospital, Sydney, New South Wales, Australia.
  • Booth DR; Western Clinical School, University of Sydney, Westmead Hospital, Sydney, New South Wales, Australia. Electronic address: david.booth@sydney.edu.au.
J Autoimmun ; 78: 57-69, 2017 03.
Article em En | MEDLINE | ID: mdl-28063629
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fenótipo / Fatores de Transcrição / Vitamina D / Autoimunidade / Esclerose Múltipla Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fenótipo / Fatores de Transcrição / Vitamina D / Autoimunidade / Esclerose Múltipla Idioma: En Ano de publicação: 2017 Tipo de documento: Article